Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype
BMC Gastroenterology · 2024
DOI: 10.1186/s12876-024-03343-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Sandra Kalthoff und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, D-53127, Bonn, Germany. sandra.kalthoff@ukbonn.de. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Immunoglobulin G, Phenotype. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Bonn.
Abstract (Originalsprache)
Background
Primary sclerosing cholangitis (PSC) is a chronic liver disease leading to inflammation with scaring and strictures of bile ducts, which can lead to liver cirrhosis. A subtype of PSC characterized by high serum IgG4 (sIgG4) levels has been reported to be associated with poor outcomes, but the exact role and the longitudinal development of sIgG4 levels in PSC progression remains to be clarified. The aim of this study was to investigate if subsequent analysis of sIgG4 levels allows the identification of the PSC phenotype with high sIgG4. Methods sIgG4 values were repeatedly analysed in a well-characterized European PSC cohort of 110 individuals. Biochemical parameters, clinical endpoints, death and liver transplantation were compared between PSC subgroups.
Results
12.7% ( n = 14) of PSC patients showed increased sIgG4 levels (PSC-IgG4). The values normalized in 57.1% ( n = 8; PSC-IgG4 norm ) during follow-up measurements, whereas the values remained permanently elevated in 42.9% ( n = 6; PSC-IgG4 const ). Serum values of AP and γGT were significantly higher in PSC-IgG4 const compared to PSC-IgG4 norm at final blood sampling. Furthermore, mean age at PSC diagnosis was markedly lower in PSC-IgG4 const compared to PSC-IgG4 norm .
Conclusions
This is the first study analyzing longitudinal development of sIgG4 in PSC. Our data indicate that only sequential determination of sIgG4 levels allow to accurately distinguish between the PSC phenotype with high sIgG4 and PSC with low sIgG4. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, D-53127, Bonn, Germany. sandra.kalthoff@ukbonn.de.
- Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, D-53127, Bonn, Germany.
- German Center for Infection Research (DZIF), Partner Site Cologne-Bonn, Bonn, Germany.
Förderung
- Universitätsklinikum Bonn
Zitieren
APA
Kalthoff, S., Wolniak, C., Lutz, P., Strassburg, C. P., Langhans, B., & Dold, L. (2024). Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03343-3
Vancouver
Kalthoff S, Wolniak C, Lutz P, Strassburg CP, Langhans B, Dold L. Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03343-3
BibTeX
@article{Kalthoff2024,
author = {Kalthoff, Sandra and Wolniak, Caroline and Lutz, Philipp and Strassburg, Christian P and Langhans, Bettina and Dold, Leona},
title = {Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype},
journal = {BMC Gastroenterology},
year = {2024},
doi = {10.1186/s12876-024-03343-3}
}
EUVIMED